Kathleen P. Rubinstein

Healthcare Policy Analyst

Houston
T 713.276.1650  |  F 713.751.1717

Kathleen P. Rubinstein is a policy analyst who partners with the Healthcare Industry and Public Policy Teams on developing and implementing strategies for achieving client policy goals and resolving their regulatory concerns. Her professional focus centers on matters involving healthcare policy including regulation under the Medicare and Medicaid programs and implementation of the Affordable Care Act.

Kathleen writes extensively on healthcare industry issues and frequently collaborates with the Healthcare Industry and Public Policy Teams on articles and presentations of topical interest. She is the Editor of the BakerHostetler Health Law Update newsletter and blog. A long time instructor at the University of Houston, Kathleen teaches a graduate seminar on healthcare policy for students of public administration, political science and the law.

Select Experience

  • Works collaboratively on developing policy recommendations and legislative proposals; formulating strategic and tactical work plans and crafting communications strategies.
  • Plans and directs the work of stakeholder advisory groups in formulating solutions to complex policy problems.
More »

Experience

  • Works collaboratively on developing policy recommendations and legislative proposals; formulating strategic and tactical work plans and crafting communications strategies.
  • Plans and directs the work of stakeholder advisory groups in formulating solutions to complex policy problems.
  • Engages in research and analysis of existing and emerging policy topics; serves as an information resource on healthcare industry issues, developments and trends. 
  • Monitors, analyzes and assesses the impact of federal and state actions, legislation and rulemaking and emerging initiatives and proposals.
  • Participates in governmental policy and regulatory interactions at state and federal levels; prepares and manages government filings and submissions.

Recognitions

  • Recognition Award, University of Houston Masters of Public Administration Program 
  • List of Outstanding Graduates, National Association of Schools Public Affairs and Administration

Memberships

  • American Hospital Association
  • American Health Lawyers Association
  • University of Houston MPA Program Alumni Network

Services

Industries

Emerging Issues

Admissions

  • [Not an Attorney]

Education

  • M.A., Public Administration, concentration in Health Policy Studies, University of Houston, 1996
  • B.A., Our Lady of the Lake University, 1992, with honors

Blog

In The Blogs

Previous Next
Health Law Update
News Flash: An Agreement Between Competitors to Limit Advertising/Marketing Violates the Antitrust Laws
April 29, 2016
For the second time in less than a year, the U.S. Department of Justice (DOJ) has filed an antitrust complaint against hospital systems that agreed to not advertise on billboards or in print in each other’s home county. Last time it was a...
Read More ->
Health Law Update
Insurer Actions Cut the Heart Out of Out-of-Network Providers
April 26, 2016
Aetna Life Insurance Company recently won a $37 million verdict against a group of Northern California surgical centers, Bay Area Surgical Management, LLC and its affiliates (collectively, Bay Area), for an alleged out-of-network...
Read More ->
Health Law Update
HHS Reopens Comment Period for Proposed Rule on 340B Drug Program
April 25, 2016
The U.S. Department of Health and Human Services (HHS) is reopening the comment period for the proposed rule titled “340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation.” HHS released the proposed...
Read More ->
Health Law Update
Biologics and Biosimilars in the U.S. and Europe
April 25, 2016
As the pace of biosimilars development picks up, many pharmaceutical companies are looking for guidance in understanding the patent and regulatory landscapes in the United States and in Europe. This seminar will provide practical advice on...
Read More ->
Health Law Update
New Medicare Part B Payment Model is Most Recent Payor Response to Increasing Drug Prices
April 20, 2016
Recent activity by the federal government along with commercial payors may be indicative of further changes to how payors, providers, and pharmaceutical manufacturers engage in prescription drug arrangements. A recently announced proposed...
Read More ->